Status: Recruiting
A Study in Subjects With Neurogenic Orthostatic Hypotension
This is a study to evaluate the effects of CST-3056 on orthostatic symptoms and signs in subjects with neurogenic orthostatic hypotension (nOH).
Participants needed: 12
Trial details
Phase: Phase 2Age: 18-85Biological sex: AllType: InterventionalSponsor: CuraSen Therapeutics, Inc.Updated: May 5, 2026Locations: 5
Eligibility criteria
Male or female subjects ≥ 18 and ≤ 85 years of age, at time of informed consent. [+12]
Systemic illnesses known to produce autonomic neuropathy, including but not limi... [+16]